Pulmonary Hypertension Associated with Idiopathic Pulmonary Fibrosis: Current and Future Perspectives.
about
Inhibition of Hyaluronan Synthesis Attenuates Pulmonary Hypertension Associated with Lung Fibrosis.Clinical physiology and sleep: insights from the European Respiratory Society Congress 2017.The Selective Angiotensin II Type 2 Receptor Agonist, Compound 21, Attenuates the Progression of Lung Fibrosis and Pulmonary Hypertension in an Experimental Model of Bleomycin-Induced Lung Injury.Switching-Off Adora2b in Vascular Smooth Muscle Cells Halts the Development of Pulmonary Hypertension.
P2860
Pulmonary Hypertension Associated with Idiopathic Pulmonary Fibrosis: Current and Future Perspectives.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 13 February 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pulmonary Hypertension Associa ...... rrent and Future Perspectives.
@en
Pulmonary Hypertension Associa ...... rrent and Future Perspectives.
@nl
type
label
Pulmonary Hypertension Associa ...... rrent and Future Perspectives.
@en
Pulmonary Hypertension Associa ...... rrent and Future Perspectives.
@nl
prefLabel
Pulmonary Hypertension Associa ...... rrent and Future Perspectives.
@en
Pulmonary Hypertension Associa ...... rrent and Future Perspectives.
@nl
P2093
P2860
P50
P921
P356
P1476
Pulmonary Hypertension Associa ...... urrent and Future Perspectives
@en
P2093
Adriana M Hernandez
Amara DiFrancesco
Ankit Hanmandlu
Ashrith Guha
Javier Amione-Guerra
Keith Youker
P2860
P304
P356
10.1155/2017/1430350
P407
P5008
P577
2017-02-13T00:00:00Z